The average import prices of biochemicals and chemical raw materials increased year-on-year, while that of western medicines decreased slightly by 5.21%.

From January to June 2012, China's imports of Western medicine products grew steadily, by 21.33% year-on-year, reaching US$9.61 billion. Western patent medicines are still the protagonists of import trade, accounting for about 50% of imports.

Europe's 6.16 billion products are imported into China. China's western medicine imports mainly come from Europe, Asia and North America. In the first half of 2012, the amount of Western medicine products imported from Europe was US$6.16 billion and showed a good growth. Both the import value and the average import price increased by more than 20% year-on-year. Imports from North America and Asia also saw double-digit growth year-on-year, at 18.74% and 11.27%, respectively, and imports were 1.18 billion and 1.81 billion, respectively.

In the first half of this year, the top ten import trading partners of western medicine products in China were Germany, the United States, Switzerland, France, Japan, Italy, the United Kingdom, Ireland, Sweden and Belgium. China's Western medicine products also mainly come from the top ten trading partners, and their total imports account for approximately 72.18%. From the perspective of import prices, the prices of imported western medicine products in China have shown a rapid upward trend. In particular, the average import prices of Ireland and Sweden have increased by more than 50% year-on-year, while in the top ten sources of imports, only Italian imports are The price dropped by a year-on-year, a drop of 32.72%, and the resulting increase in import volume was also up 123% year-on-year.

Biochemicals imports increased by 48.02%

In the first half of 2012, among the three categories of commodities included in Western medicine products, the import volume of Western medicines was US$4.77 billion, up by 27.84% year-on-year; the import volume of chemical raw materials was US$3.55 billion, up by 7.01% year-on-year. Biochemicals imports The amount of 1.29 billion US dollars, an increase of 48.02%. From the perspective of average import prices, both biochemical drugs and chemical raw material drugs increased year-on-year, while Western medicines decreased slightly by 5.21%.

The average import prices of hormones, cephalosporins, and vitamins decreased significantly compared with the same period of last year, which was about 10%. The average import price of penicillin drugs increased by 43.92% year-on-year, but imports and imports decreased by 40.55% and 14.44% respectively.

From the perspective of product structure, "other dosed drugs" continue to sit steadily on the forehead of imports, with an import volume of 2.98 billion U.S. dollars, an increase of 35.34% year-on-year, accounting for 31.01% of the total imports of western drug products. The import volume of “anti-serum and other blood components and modified immune products” was also relatively large, ranking the second place in the import of western medicine products, which was US$908 million.

In the first half of 2012, there were a total of 5,100 enterprises that imported western medicine products in China, of which 53% were foreign-funded enterprises, 38% were private enterprises, and 9% were state-owned enterprises. The foreign-funded enterprises not only occupy an advantage in the number of imported companies, but also play a leading role in the amount of imports. Among them, the import value of Western medicine products of foreign-funded enterprises was US$6.03 billion, an increase of 21.22% over the same period of last year, of which the foreign-owned enterprises’ import value was US$3.57 billion, an increase of 22.51% over the same period of last year.